A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

NCT04106297 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lakefront Biotherapeutics NV